Literature DB >> 17977646

Influence of oxygen tension on CD133 phenotype in human glioma cell cultures.

Nadine Platet1, Shi Yong Liu, Michèle El Atifi, Lisa Oliver, François M Vallette, François Berger, Didier Wion.   

Abstract

Under standard culture conditions, tumor cells are exposed to 20% O(2), whereas the mean tumor oxygen levels within the tumor are much lower. We demonstrate, using low-passaged human tumor cell cultures established from glioma, that a reduction in the oxygen level in these cell cultures dramatically increases the percentage of CD133 expressing cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17977646     DOI: 10.1016/j.canlet.2007.09.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  61 in total

1.  CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope.

Authors:  Anthony B Mak; Kim M Blakely; Rashida A Williams; Pier-Andrée Penttilä; Andrey I Shukalyuk; Khan T Osman; Dahlia Kasimer; Troy Ketela; Jason Moffat
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

2.  Characterisation of normal and cancer stem cells: one experimental paradigm for two kinds of stem cells.

Authors:  Jean-François Mayol; Corinne Loeuillet; Francis Hérodin; Didier Wion
Journal:  Bioessays       Date:  2009-09       Impact factor: 4.345

3.  CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell line HCT-116.

Authors:  Claudia Dittfeld; Antje Dietrich; Susann Peickert; Sandra Hering; Michael Baumann; Marian Grade; Thomas Ried; Leoni A Kunz-Schughart
Journal:  Radiother Oncol       Date:  2010-03       Impact factor: 6.280

4.  A theory and a model to understand glioblastoma development both in the bulk and in the microinfiltrated brain parenchyma.

Authors:  Enrico Brognaro
Journal:  Neurochem Res       Date:  2011-07-08       Impact factor: 3.996

Review 5.  The changing paradigm of tumour response to irradiation.

Authors:  Richard P Hill
Journal:  Br J Radiol       Date:  2016-08-02       Impact factor: 3.039

6.  Immunotoxin targeting CD133(+) breast carcinoma cells.

Authors:  John R Ohlfest; David M Zellmer; Jayanth Panyam; Suresh Kumar Swaminathan; Seunguk Oh; Nate N Waldron; Shoko Toma; Daniel A Vallera
Journal:  Drug Deliv Transl Res       Date:  2013-04       Impact factor: 4.617

7.  A tumor hypoxic niche protects human colon cancer stem cells from chemotherapy.

Authors:  Qin Mao; Yu Zhang; Xiaoyue Fu; Jianxin Xue; Wenhao Guo; Maobing Meng; Zongguang Zhou; Xianming Mo; You Lu
Journal:  J Cancer Res Clin Oncol       Date:  2012-09-30       Impact factor: 4.553

Review 8.  Hypoxia-Mediated Mechanisms Associated with Antiangiogenic Treatment Resistance in Glioblastomas.

Authors:  Sean Mahase; Rachel N Rattenni; Pieter Wesseling; William Leenders; Clarissa Baldotto; Rajan Jain; David Zagzag
Journal:  Am J Pathol       Date:  2017-03-09       Impact factor: 4.307

9.  Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15.

Authors:  Xing-Gang Mao; Xiang Zhang; Xiao-Yan Xue; Geng Guo; Peng Wang; Wei Zhang; Zhou Fei; Hai-Ning Zhen; Si-Wei You; Hao Yang
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

10.  Rapid re-expression of CD133 protein in colorectal cancer cell lines in vitro and in vivo.

Authors:  Susann Peickert; Julia Waurig; Claudia Dittfeld; Antje Dietrich; Yvette Garbe; Lydia Kabus; Michael Baumann; Marian Grade; Thomas Ried; Leoni A Kunz-Schughart
Journal:  Lab Invest       Date:  2012-09-10       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.